Methylation in the p53 Promoter Is a Supplementary Route to Breast Carcinogenesis: Correlation between CpG Methylation in the p53 Promoter and the Mutation of the p53 Gene in the Progression from Ductal Carcinoma In Situ to Invasive Ductal Carcinoma

This publication has 21 references indexed in Scilit:

• Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP-1, NF-κB and Myc/Max
  Oncogene, 1999
• Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation
  The EMBO Journal, 1998
• CpG Methylation Inactivates the Transcriptional Activity of the Promoter of the Humanp53Tumor Suppressor Gene
  Biochemical and Biophysical Research Communications, 1997
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
  Proceedings of the National Academy of Sciences, 1996
• 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
  Nature Medicine, 1995
• Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.
  Proceedings of the National Academy of Sciences, 1994
• DNA methylation and mutation
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1993
• The essentials of DNA methylation
  Published by Elsevier ,1992
• p53 Mutations in Human Cancers
  Science, 1991
• Ha-ras and c-myc oncogene expression interferes with morphological and functional differentiation of mammary epithelial cells in single and double transgenic mice.
  Genes & Development, 1988